Crossmark Global Holdings’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-4,790
| Closed | -$208K | – | 1354 |
|
|
2021
Q4 | $208K | Sell |
4,790
-4,190
| -47% | -$182K | ﹤0.01% | 1322 |
|
|
2021
Q3 | $450K | Sell |
8,980
-10
| -0.1% | -$501 | 0.01% | 971 |
|
|
2021
Q2 | $566K | Sell |
8,990
-280
| -3% | -$17.6K | 0.01% | 853 |
|
|
2021
Q1 | $861K | Buy |
9,270
+190
| +2% | +$17.6K | 0.02% | 645 |
|
|
2020
Q4 | $814K | Buy |
9,080
+5,190
| +133% | +$465K | 0.02% | 632 |
|
|
2020
Q3 | $402K | Sell |
3,890
-350
| -8% | -$36.2K | 0.01% | 865 |
|
|
2020
Q2 | $335K | Buy |
4,240
+20
| +0.5% | +$1.58K | 0.01% | 952 |
|
|
2020
Q1 | $244K | Sell |
4,220
-110
| -3% | -$6.36K | 0.01% | 957 |
|
|
2019
Q4 | $234K | Buy |
4,330
+10
| +0.2% | +$540 | 0.01% | 1264 |
|
|
2019
Q3 | $226K | Sell |
4,320
-100
| -2% | -$5.23K | 0.01% | 1205 |
|
|
2019
Q2 | $214K | Buy |
4,420
+10
| +0.2% | +$484 | 0.01% | 1271 |
|
|
2019
Q1 | $223K | Buy |
4,410
+20
| +0.5% | +$1.01K | 0.01% | 1267 |
|
|
2018
Q4 | $260K | Sell |
4,390
-7,310
| -62% | -$433K | 0.01% | 1157 |
|
|
2018
Q3 | $770K | Buy |
11,700
+1,000
| +9% | +$65.8K | 0.02% | 717 |
|
|
2018
Q2 | $540K | Buy |
10,700
+520
| +5% | +$26.2K | 0.01% | 896 |
|
|
2018
Q1 | $536K | Sell |
10,180
-1,320
| -11% | -$69.5K | 0.01% | 872 |
|
|
2017
Q4 | $534K | Buy |
11,500
+4,390
| +62% | +$204K | 0.01% | 948 |
|
|
2017
Q3 | $288K | Buy |
+7,110
| New | +$288K | 0.01% | 1343 |
|
|
2016
Q3 | $288K | Buy |
+7,110
| New | +$288K | 0.01% | 1343 |
|